# OnCo record nct07059845 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07059845/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07059845", "NCT07059845" ;
  schema:name "A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult"@en ;
  schema:alternateName "FLORENZA"@en ;
  schema:description "A phase 2 trial of Mirvetuximab soravtansine, Bevacizumab, Carboplatin in ovarian cancer, run by AbbVie, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07059845/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07059845> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-11-13" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/mirvetuximab-soravtansine/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .